These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15010143)

  • 61. The solubility behaviour and thermodynamic relations of the three forms of Venlafaxine free base.
    van Eupen JT; Westheim R; Deij MA; Meekes H; Bennema P; Vlieg E
    Int J Pharm; 2009 Feb; 368(1-2):146-53. PubMed ID: 18996456
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pseudopolymorphism and phase stability in four solid forms of (6R,7R)-7-[2-(5-amino-1,2,4-thiadiazol-3-yl)-(Z)-2-methoxy- iminoacetamid]-3- [(4-carbamoyl-1-quinuclidinio)methyl]-8-oxo-5-thia-1-azabicyclo - [4,2,0]oct-2-ene-2-carboxylate (E1040).
    Ashizawa K; Uchikawa K; Hattori T; Ishibashi Y; Sato T; Miyake Y
    J Pharm Sci; 1989 Nov; 78(11):893-9. PubMed ID: 2621570
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of moisture on the crystal forms of niclosamide obtained from acetone and ethyl acetate.
    Manek RV; Kolling WM
    AAPS PharmSciTech; 2004 Mar; 5(1):E14. PubMed ID: 15198535
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stable carbamazepine colloidal systems using the cosolvent technique.
    Douroumis D; Fahr A
    Eur J Pharm Sci; 2007 Apr; 30(5):367-74. PubMed ID: 17234395
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form.
    Hasegawa G; Komasaka T; Bando R; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
    Int J Pharm; 2009 Mar; 369(1-2):12-8. PubMed ID: 19026732
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of cocrystals in pharmaceutical science.
    Shan N; Zaworotko MJ
    Drug Discov Today; 2008 May; 13(9-10):440-6. PubMed ID: 18468562
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of CP/MAS solid-state NMR for the characterization of solvate molecules within estradiol crystal forms.
    Park JS; Kang HW; Park SJ; Kim CK
    Eur J Pharm Biopharm; 2005 Aug; 60(3):407-12. PubMed ID: 15996582
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stability of the crystalline form of cefaclor monohydrate and its pharmaceutical preparations.
    Medenecka B; Jelińska A; Zajac M; Bałdyka M; Juszkiewicz K; Oszczapowicz I
    Acta Pol Pharm; 2009; 66(5):563-9. PubMed ID: 19894653
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Batch cooling crystallization and pressure filtration of sulphathiazole: the influence of solvent composition.
    Häkkinen A; Pöllänen K; Karjalainen M; Rantanen J; Louhi-Kultanen M; Nyström L
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):17-28. PubMed ID: 15283678
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Formation of a new crystalline form of anhydrous β-maltose by ethanol-mediated crystal transformation.
    Verhoeven N; Neoh TL; Ohashi T; Furuta T; Kurozumi S; Yoshii H
    Carbohydr Res; 2012 Apr; 351():74-80. PubMed ID: 22341504
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of hydrate-screening methods.
    Cui Y; Yao E
    J Pharm Sci; 2008 Jul; 97(7):2730-44. PubMed ID: 17914731
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Application of NIR spectroscopy in polymorphic analysis: study of pseudo-polymorphs stability.
    Blanco M; Valdés D; Llorente I; Bayod M
    J Pharm Sci; 2005 Jun; 94(6):1336-42. PubMed ID: 15858852
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure, Solubility and Stability of Orbifloxacin Crystal Forms: Hemihydrate versus Anhydrate.
    Santos OM; Freitas JT; Cazedey EC; de Araújo MB; Doriguetto AC
    Molecules; 2016 Mar; 21(3):328. PubMed ID: 27005603
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predicting Deliquescence Relative Humidities of Crystals and Crystal Mixtures.
    Veith H; Luebbert C; Sadowski G
    Molecules; 2021 May; 26(11):. PubMed ID: 34073307
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Crystallization of a polymorphic hydrate system.
    Tian F; Qu H; Louhi-Kultanen M; Rantanen J
    J Pharm Sci; 2010 Feb; 99(2):753-63. PubMed ID: 19569226
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Physical transformation of niclosamide solvates in pharmaceutical suspensions determined by DSC and TG analysis.
    de Villiers MM; Mahlatji MD; Malan SF; van Tonder EC; Liebenberg W
    Pharmazie; 2004 Jul; 59(7):534-40. PubMed ID: 15296091
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Crystal transformation from anhydrous alpha-maltose to hydrous beta-maltose and from anhydrous trehalose to hydrous trehalose.
    Yoshii H; Furuta T; Kudo J; Linko P
    Biosci Biotechnol Biochem; 2000 Jun; 64(6):1147-52. PubMed ID: 10923783
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Stability of a hydrophobic drug in presence of hydrous and anhydrous lactose.
    Jain R; Railkar AS; Malick AW; Rhodes CT; Shah NH
    Eur J Pharm Biopharm; 1998 Sep; 46(2):177-82. PubMed ID: 9795047
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Understanding Phase Behavior of Nearly Energetically Equivalent Polymorphs To Achieve Controlled Crystallization for a Nav1.7 Pain Inhibitor Compound.
    Chakravarty P; DiPasquale AG; Stumpf A; Lubach JW; Nagapudi K
    Mol Pharm; 2018 Nov; 15(11):5072-5080. PubMed ID: 30216726
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Solubility behavior of lamivudine crystal forms in recrystallization solvents.
    Jozwiakowski MJ; Nguyen NA; Sisco JM; Spancake CW
    J Pharm Sci; 1996 Feb; 85(2):193-9. PubMed ID: 8683448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.